UK MHRA 'Could Set Up Standalone System' But Faces Post-Brexit Loss Of Income & Influence
The UK regulator is realistic about the threats Brexit poses to its income and influence, but is confident it can set up a standalone regulatory system and has some ideas for working with the European Medicines Agency under the future relationship between the UK and the EU.
You may also be interested in...
UK And EMA Could Work Together Informally After Brexit
The UK may not be able to participate in the European Medicines Agency after Brexit, but there are plenty of precedents for informal collaboration among regulatory agencies worldwide. A former European Medicines Agency executive director and legal experts talk to the Pink Sheet about what might be possible.
UK Industry ‘Struggling’ With Skill Gaps In AI, Robotics & Data Analytics
A new report says that pharma firms are finding it difficult to recruit staff with experience in emerging scientific technologies, particularly in areas such as regulatory and quality assurance. COVID-19, Brexit and competition for talent with other countries and industry sectors are cited as key factors.